[Flash glucose monitoring system in diabetes mellitus patients]

Sáenz V, Soto N, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A. Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A
Record ID 32018001502
Spanish
Original Title: Sistema flash para monitoreo de glucemia en pacientes con diabetes mellitus
Authors' recomendations: CONCLUSIONS High-quality evidence shows that the Flash Glucose Monitoring System, version for patients, compared with the test strip monitoring system considerably decreases clinically significant hypoglycemias, in adults with type 2 diabetes receiving insulin therapy with inadequate metabolic control as well as in adults with type 1 diabetes with an adequate metabolic control. Low-quality evidence suggests that the Flash Glucose Monitoring System might provide positive results in the quality of life and glucose control in patients 13 to 19 years old under treatment with insulin when compared with the test strip monitoring system. Low-quality evidence suggests that the Flash Glucose Monitoring System, version for patients, does not significantly reduce time with hypoglycemia when compared with continuous monitoring in adult patients with type 1 diabetes and high risk for hypoglycemia. Most coverage policies from high-income countries surveyed recommend the use of the Flash Glucose Monitoring System to control diabetic patients receiving insulin therapy, over 4 years old or over 18 years old in other cases. Most clinical practice guidelines mention its use in diabetic patients receiving insulin therapy, based on their type of diabetes and metabolic control. No cost-effectiveness evidence was found in the local setting. In some high-income countries, the incremental cost-effectiveness ratio remains within the accepted range.
Details
Project Status: Completed
Year Published: 2018
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Diabetes Mellitus, Type 1
  • Blood Glucose Self-Monitoring
  • Hypoglycemia
  • Diabetes Mellitus, Type 2
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.